Internal Medicine, Pulmonary Disease · Houston, TX
NPI
1558757104
Since 2015
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6550 Fannin St Ste 1001
Houston, TX, 77030
Phone (513) 540-9154
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,015 services
Medicare patients, 2024
230
Average age 68
Drug cost, 2024
$1.6M
3,097 prescriptions
Company payments, 2025
$403
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mena Botros was code 99233 (hospital e&m - subsequent), 416 times for 64 patients. In total Mena Botros billed 1,015 services in 22 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 416 | 64 | $93.60 | $39K |
| 99215 Office E&M - Established | Facility | 316 | 181 | $102.89 | $33K |
| 99291 Critical Care E&M | Facility | 77 | 19 | $159.59 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 26 | $62.85 | $2,640 |
| 99214 Office E&M - Established | Facility | 30 | 24 | $71.00 | $2,130 |
| 31624 Bronchoscopy | Facility | 30 | 24 | $103.94 | $3,118 |
| 99152 Anesthesia | Facility | 27 | 25 | $9.44 | $255 |
| 99222 Hospital E&M - Initial | Facility | 27 | 24 | $104.61 | $2,825 |
| 31628 Bronchoscopy | Facility | 14 | 14 | $128.84 | $1,804 |
By year: 2022 $43K for 478 services; 2023 $81K for 811 services; 2024 $100K for 1,015 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mena Botros prescribed most often to Medicare patients was Prednisone, with 265 prescriptions and refills. In total Mena Botros wrote 3,097 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 265 | 515 | 111 | $1,700 |
| Azithromycin Generic | 263 | 592 | 94 | $5,093 |
| Tacrolimus Generic | 153 | 296 | 45 | $16K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 134 | 276 | 51 | $708 |
| Pantoprazole Sodium Generic | 107 | 261 | 42 | $1,638 |
| Metoprolol Tartrate Generic | 100 | 229 | 37 | $670 |
| Valganciclovir Hcl Generic | 97 | 173 | 40 | $24K |
| Atovaquone Generic | 93 | 138 | 28 | $45K |
| Rosuvastatin Calcium Generic | 92 | 193 | 34 | $1,070 |
| Montelukast Sodium Generic | 72 | 176 | 25 | $649 |
| Eliquis Apixaban | 67 | 89 | 24 | $47K |
| Voriconazole Generic | 63 | 117 | 25 | $27K |
| Gabapentin Generic | 54 | 90 | 20 | $789 |
| Furosemide Generic | 54 | 98 | 23 | $165 |
| Metoclopramide Hcl Generic | 51 | 96 | 20 | $421 |
Brand drugs: - claims; generic drugs: 2,691 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mena Botros $403 ($403 in general payments such as food, travel and fees) from 5 companies. The largest payer was GlaxoSmithKline, LLC. with $161.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.